Home · Peptides · Larazotide
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

Larazotide

THE GUT SEALER

AT-1001; Larazotide Acetate

Larazotide is designed to close the gaps between intestinal cells that cause "leaky gut." It blocks zonulin, a protein that opens these gaps and allows food particles and bacteria to leak into your bloodstream. Originally developed for celiac disease, it may help anyone with intestinal permeability issues.

Larazotide
Larazotide
Larazotide

Larazotide Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

May 8, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Larazotide

◆

Is Larazotide FDA approved?

No. This profile records Larazotide as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Larazotide?

Dose: 0.5-1 mg three times daily before meals.

MORE CONTEXT ›

Schedule: daily. Cycle: Ongoing for gut barrier support. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Larazotide guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Zonulin Blocker

Prevents zonulin from opening tight junctions

Barrier Restoration

Keeps intestinal cells tightly connected

Inflammation Reduction

Reduces immune activation from leaked antigens

People with celiac disease
Those with leaky gut syndrome
Crohn's disease patients
Anyone with food sensitivities
People with IBS

Larazotide Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.